Role of alanyl aminopeptidase in growth and function of human T cells (Review)

International Journal of Molecular Medicine

Volumn 4, Issue 1, 1999, Pages 17-27

  Lendeckel, Uwe ^a   Arndt, Marco ^a   Frank, Karin ^a   Wex, Thomas ^a   Ansorge, Siegfried ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Alanyl aminopeptidase; T cells

Indexed keywords

CYTOKINE; ENZYME INHIBITOR; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; PRIMER DNA;

BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA; LYMPHOCYTE ACTIVATION; LYMPHOMA; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD13; BASE SEQUENCE; CELL DIVISION; CYTOKINES; DNA PRIMERS; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; LEUKEMIA; LYMPHOCYTE ACTIVATION; LYMPHOMA; MODELS, BIOLOGICAL; MUTATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0033161643     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.4.1.17     Document Type: Article

References (88)

1. Rawlings ND and Barrett AJ: Evolutionary families of peptidases. Biochem J 290: 205-218, 1993.
2. Hooper NM: Families of zinc metalloproteases. FEBS Lett 354: 1-6, 1994.
3. Look AT, Ashmun RA, Shapiro LH and Peiper SC: Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 83: 1299-1307, 1989.
4. Watt VM and Willard HF: The human aminopeptidase N gene: isolation, chromosome localization, and DNA polymorphism analysis. Hum Genet 85: 651-654, 1990.
5. Lerche C, Vogel LK, Shapiro LH, Noren O and Sjöström H: Human aminopeptidase N is encoded by 20 exons. Mamm Genome 7: 712-713, 1996.
6. Barnes K, Walkden BJ, Wilkinson TC and Turner AJ: Expression of endothelin-converting enzyme in both neuroblastoma and glial cell lines and its localization in rat hippocampus. J Neurochem 68: 570-577, 1997.
7. Lucius R, Sievers J and Mentlein R: Enkephalin metabolism by microglial aminopeptidase N (CD13). J Neurochem 64: 1841-1847, 1995.
8. Olsen J, Laustsen L, Karnstrom U, Sjöström H and Noren O: Tissue-specific interactions between nuclear proteins and the aminopeptidase N promoter. J Biol Chem 266: 18089-18096, 1991.
9. Shapiro LH, Ashmun RA, Roberts WM and Look AT: Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells. J Biol Chem 266: 11999-12007, 1991.
10. Hedge SP, Kumar A, Kürschner C and Shapiro LH: c-Maf interacts with c-Myb to regulate tanscription of an early myeloid gene during differentiation. Mol Cell Biol 18: 2729-2737, 1998.
11. Shapiro LH: Myb and Ets proteins cooperate to transactivate an early myeloid gene. J Biol Chem 270: 8763-8771, 1995.
12. Yang C, Shapiro LH, Rivera M, Kumar A and Brindle PK: A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol Cell Biol 18: 2218-2229, 1998.
13. Olsen J, Kokholm K, Troelsen T and Laustsen L: An enhancer with cell-type dependent activity is located between the myeloid and epithelial aminopeptidase N (CD13) promoters. Biochem J 322: 899-908, 1997.
14. Mizutani S, Goto K, Nomura S, Ino K, Goto S, Kikkawa F, Kurauchi O, Goldstein G and Tomoda Y: Possible action of human placental aminopeptidase N in feto-placental unit. Res Commun Chem Pathol Pharmacol 82: 65-80, 1993.
15. Ahmad S, Wang L and Ward PE: Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo. J Pharmacol Exp Thcr 260: 1257-1261, 1992.
16. Furuhashi M, Mizutani S, Kurauchi O, Kasugai M, Narita O and Tomoda Y: In vitro degradation of opioid peptides by human placental aminopeptidase M. Exp Clin Endocrinol 92: 235-237, 1988.
17. Giros B, Gros C, Solhonne B and Schwanz JC: Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Mol Pharmacol 29: 281-287, 1986.
18. Shimamura M, Hazato T and Iwaguchi T: A new aminopeptidase in monkey cerebral membrane fraction: hydrolysis of enkephalin. Brain Res 445: 350-353, 1988.
19. Shimamura M, Hazato T and Iwaguchi T: Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides. J Biochem 109: 492-497, 1991.
20. Ward PE, Benter IF, Dick L and Wilk S: Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. Biochem Pharmacol 40: 1725-1732, 1990.
21. + spleen T cells. Arch Biochem Biophys 311: 174-179, 1994.
22. Miller BC, Ackroyd A, Hersh LB and Cottam GL: Methionine enkephalin metabolism by murine macrophage ectopeptidase(s). Regul Pept 50: 87-98, 1994.
23. Shibanoki S, Weinberger SB, Ishikawa K and Martinez JL Jr: Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations. Regul Pept 32: 267-278, 1991.
24. Hoffmann T, Faust J, Neubert K and Ansorge S: Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokincs and peptides with N-terminal cytokine sequences. FEBS Lett 336: 61-64, 1993.
25. Kanayama N, Kajiwara Y, Goto J, E1 Maradny E, Maehara K, Andou K and Terao T: Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 57: 129-134, 1995.
26. Mathe G: Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system? Cancer Detect Prev (Suppl. 1): 445-455, 1987.
27. Chansel D, Czekalski S, Vandermeersch S, Ruffet E, FoumicZaluski MC and Ardaillou R: Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells. Am J Physiol 275: F535-F542, 1998.
28. Palmieri FE, Petrelli JJ and Ward PE: Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides. Biochem Pharmacol 34: 2309-2317, 1985.
29. Palmieri FE, Bausback HH and Ward PE: Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. Biochem Pharmacol 38: 173-180, 1989.
30. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I and Tsuruo T: Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CDI3. Clin Exp Metastasis 13: 337-344, 1995.
31. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T and Azuma I: Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54: 137-143, 1993.
32. Hansen AS, Noren O, Sjöström H and Werdelin O: A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules. Eur J Immunol 23: 2358-2364, 1993.
33. Delmas B, Gelfi J, L'Haridon R, Vogel LK, Sjöström H, Noren O and Laude H: Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 357: 417-420, 1992.
34. Delmas B, Gelfi J, Sjöström H, Noren O and Laude H: Further characterization of aminopeptidase-N as a receptor for coronaviruses. Adv Exp Med Biol 342: 293-298, 1993.
35. Delmas B, Gelfi J, Kut E, Sjöström H, Noren O and Laude H: Determinants essential for the transmissible gastroenteritis virusreceptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. J Virol 68: 5216-5224, 1994.
36. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT and Holmes KV: Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357: 420-422, 1992.
37. Giugni TD, Södcrberg C, Ham DJ, Bautista RM, Hedlund K-O, Möller E and Zaia JA: Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis 173: 1062-1071, 1996.
38. Söderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM and Möller E: CD13 (human aminopeptidasc N) mediates human cytomegalovirus infection. J Virol 67: 6576-6585, 1993.
39. Dreno B, Bureau B, Stalder JF and Litoux P: MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma. Arch Dermatol 126: 1454-1456, 1990.
40. Drexler HG, Thiel E and Ludwig W-D: Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5: 637-645, 1991.
41. Guyotat D, Campos L, Shi ZH, Charrin C, Treille D, Magaud JP and Fiere D: Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 4: 664-666, 1990.
42. Matsushita A, Nagai K, Ishikawa T, Tatsumi E, Ohno Y and Takahashi T: B-cell prolymphocytic leukemia expressing CD13 antigen. Int J Hematol 60: 157-161, 1994.
43. Pinto A, Del Vecchio L, Carbone A, Roncadin M, Volpe R, Serraino D, Monfardini S, Colombatti A and Zagonel V: Expression of myclomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia. Ann Oncol 2 (Suppl. 2): 107-113, 1991.
44. Ansorge S, Schön E and Kunz D: Membrane-bound peptidases of lymphocytes: functional implications. Biomed Biochim Acta 50: 799-807, 1991.
45. Kunz D, Bühling F, Hütter HJ, Aoyagi T and Ansorge S: Aminopeptidase N (CD13, EC 3.3.4.11.2) occurs on the surface of resting and concanavalin A-stimulated lymphocytes. Biol Chem Hoppe Seyler 374: 291-296, 1993.
46. Riemann D, Schwachula A, Hentschel M and Langner J: Demonstration of CD13/aminopeptidase N on synovial fluid T cells from patients with different forms of joint effusions. Immunobiology 187: 24-35, 1993.
47. Riemann D, Wollert HG, Menschikowski J, Mittcnzwei S and Langner J: Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol 104: 48-56, 1994.
48. Riemann D, Kehlen A and Langner J: CD13 - not just a marker in leukemia typing. Immunol Today 20: 83-88, 1999.
49. Lendeckel U, Wex T, Kähne T, Frank K, Reinhold D and Ansorge S: Expression of the aminopeptidasc N (CD13) gene in the human T cell lines HuT78 and H9. Cell Immunol 153: 214-226, 1994.
50. Look AT, Peiper SC, Rebcntisch MB, Ashmun RA, Roussel MF, Lemons RS, Le Beau MM, Rubin CM and Sherr CJ: Molecular cloning, expression, and chromosomal localization of the gene encoding a human myeloid membrane antigen (gp150). J Clin Invest 78: 914-921, 1986.
51. Wex T, Lendeckel U, Wex H, Frank K and Ansorge S: Quantification of aminopeptidase N mRNA in T cells by competitive PCR. FEBS Lett 374: 341-344, 1995.
52. Thiele K, Riemann D, Kehlen A, Löhn M, Vogel LK and Langner J: Two transfected endothelial cell lines expressing high levels of membrane bound or soluble aminopeptidase N. Adv Exp Med Biol 421: 81-84, 1997.
53. Lendeckel U, Wex T, Reinhold D, Kähne T, Frank K, Faust J, Neubert K and Ansorge S: Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation. Biochem J 319: 817-823, 1996.
54. Lendeckel U, Wex T, Ittcnson A, Arndt M, Frank K, Mayboroda I, Schubert W and Ansorge S: Rapid mitogeninduced aminopeptidase N surface expression in human T cells is dominated by mechanisms independent of de novo protein biosynthesis. Immunobiology 197: 55-69, 1997.
55. Belhacene N, Mari B, Rossi B and Auberger P: Characterization and purification of T lymphocyte aminopeptidase B: a putative marker of T cell activation. Eur J Immunol 23: 1948-1955, 1993.
56. Schön E, Jahn S, Kicssig ST, Dcmuth HU, Neubert K, Barth A, Von Bachr R and Ansorge S: The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 17: 1821-1826, 1987.
57. Schön E, Demuth H-U, Eichmann E, Horst H-J, Körner I-J, Kopp J, Mattern T, Neubert K, Noll F, Ulmer AJ, Barth A and Ansorge S: Dipeptidyl peptidase IV in human T lymphocytes. Scand J Immunol 29: 127-132, 1989.
58. Racioppi L, Moscarella A, Ruggiero G, Manzo C, Ferrone S, Fontana S and Zappacosta S: Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induccd T cell proliferation. J Immunol 145: 3635-3640, 1990.
59. Shipp MA and Reinhcrz EL: Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogcnic T3 and T11 activation signals. J Immunol 139: 2143-2148, 1987.
60. Riemann D, Kehlen A, Thiele K, Löhn M and Langner J: Induction of aminopeptidase N/CD13 on human lymphocytes after adhesion to fibroblast-like synoviocytes, endothelial cells, epithelial cells, and monocytes/macrophages. Immunology 158: 1997.
61. Werfel T, Sonntag G, Weber MH and Götze O: Rapid increases in the membrane expression of neutral endopeptidase (CD 10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fc gamma-RIII (CDI6) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 147: 3909-3914, 1991.
62. Daniclsen EM, Cowell CM, Noren O, Sjostrom H and Dorling PR: Biosynthesis of intestinal microvillar proteins. The effect of swainsonine on post-translational processing of aminopeptidase N. Biochem J 216: 325-331, 1983.
63. Danielsen EM and Cowell GM: Biosynthesis of intestinal microvillar proteins. Processing of N-linked carbohydrate is not required for surface expression. Biochem J 240: 777-782, 1986.
64. Danielsen EM and Olsen J: Biosynthesis of intestinal microvillar proteins. Effect of castanospermine on cell-free synthesis of aminopeptidase N. FEES Lett 228: 102-104, 1988.
65. Danielsen EM: Post-translational suppression of expression of intestinal brush border enzymes by fructose. J Biol Chem 264: 13726-13729, 1989.
66. Daniclsen EM: Folding of intestinal brush border enzymes. Evidence that high-mannose glycosylation is an essential early event. Biochemistry 31: 2266-2272, 1992.
67. Ino K, Goto S, Kosaki A, Nomura S, Asada E, Misawa T, Furuhashi Y, Mizutani S and Tomoda Y: Groth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro. Biotherapy 3: 351-357, 1991.
68. Ino K, Isobc K, Goto S, Nakashima I and Tomoda Y: Inhibitory effect of bestatin on the growth of human lymphocytes. Immunopharmacology 23: 163-171, 1992.
69. Ino K, Goto S, Okamoto T, Nomura S, Nawa A, Isobe K, Mizutani S and Tomoda Y: Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity. Jpn J Cancer Res 85: 927-933, 1994.
70. Inoi K, Goto S, Nomura S, Isobe K, Nawa A, Okamoto T and Tomoda Y: Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity. Anticancer Res 15: 20812087, 1995.
71. Sakurada K, Imamura M, Kobayashi M, Tachibana N, Abe K, Tanaka M, Okabe M, Morioka M, Kasai M and Sugiura T: Inhibitory effect of bestatin on the growth of human leukemic cells. Acta Oncol 29: 799-802, 1990.
72. Powers JC and Harper JW: Inhibitors of metalloproteases. In: Proteinase Inhibitors. Barrett AJ and Salvesen G (cds). Elsevier, Amsterdam, pp219-298, 1986.
73. Tieku S and Hooper NM: Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem Pharmacol 44: 1725-1730, 1992.
74. Lendeckel U, Kähne T, Arndt M, Frank K and Ansorge S: Inhibition of alanyl aminopeptidase induces MAP-kinase p42/ ERK2 in the human T cell line KARPAS-299. Biochem Biophys Res Commun 252: 5-9, 1998.
75. Wex T, Lendeckel U, Reinhold D, et al: Antisensc-mediated inhibition of aminopeptidase N (CD 13) markedly decreases growth rates of hematopoictie tumour cells. In: Cellular Peptidases in Immune Function and Diseases. Ansorge S and Langner J (eds). Plenum Press, New York, pp67-73, 1997.
76. Marshall C: Specifity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-related kinase activation. Cell 80: 179-185, 1995.
77. Berhow M, Hiroi N and Nestler E: Regulation of ERK (extracellular signal regulated kinase), part of the neurothrophin signal transduction eascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16: 4707-4715, 1996.
78. Gutstein HB, Rubie EA, Mansour A, Akil H and Woodgett JR: Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology 87: 1118-1126, 1997.
79. Nestler E: Under siege: the brain on opiates. Neuron 16: 897-900, 1996.
80. Ortiz J, Harris H, Guitart X, Terwilliger R, Haycock J and Nestler E: Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15: 1285-1297, 1995.
81. Murata M, Kubota Y, Tanaka T, Iida-Tanaka K and Takahara JIS: Effect of ubenimex on the proliferation ans differentiation of U937 human histiocytic lymphoma cells. Leukemia 8: 2188-2193, 1994.
82. Löhn M, Mueller C, Thiel K, Kähne T, Riemann D and Langner J: Aminopeptidase N-mediated signal transduction and inhibition of proliferation of human myeloid cells. Adv Exp Med Biol 421: 85-91, 1997.
83. Lendeckel U, Wex T, Arndt M, Frank K, Franke A and Ansorge S: Identification of point mutations in the aminopeptidase N gene by SSCP analysis and sequencing. Hum Mutat (Suppl. 1): S158-S160, 1998.
84. Collyn d'Hooghe M, Galiegue-Zouitina S, Szymiczek D, Lantoine D, Quief S, Loucheux-Lefebvre MH and Kerckaert JP: Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies. Leukemia?: 1777-1785, 1997.
85. Papas TS, Watson DK, Sacchi N, Fujiwara S, Seth AK, Fisher RJ, Bhat NK, Mavrothalassitis G, Koizumi S and Jornvall H: ETS family of genes in leukemia and Down syndrome. Am J Med Genet Suppl 7: 251-261, 1990.
86. Sidorowicz W, Zownir O and Behal FJ: Action of human pancreas alanine aminopeptidase on biologically active peptides: kinin converting activity. Clin Chim Acta 111: 69-79, 1981.
87. Lachance C, Arbour A, Cashman NR and Talbot PJ: Involvement of aminopeptidase N (CD13) in infection of human neural cells by human corona virus 229E. J Virol 72: 6511-6519, 1998.
88. Kähne T, Lendeckel U, Wrenger S, Neubert K, Ansorge S and Reinhold D: Dipeptidyl peptidase IV: A cell surface peptidase involved in regulating T cell growth. Int J Mol Med 4: 17-27, 1999.